Why is Remus Pharma. falling/rising?

As of 23-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 785.90, down by Rs 12.6 or 1.58%. The stock has underperformed its sector by 1.23% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has decreased by 4.08%, and it has seen a significant drop of 16.61% over the past month. Additionally, it is currently 1.39% away from its 52-week low of Rs 775. Despite this decline, there has been a notable increase in investor participation, with delivery volume rising by 322.02% against the 5-day average, indicating some interest in the stock despite its recent performance.
In the broader market context, the Sensex has shown a slight decline of 0.28% over the past week, while Remus Pharmaceuticals has significantly underperformed against this benchmark. Year-to-date, the stock has fallen by 37.07%, contrasting sharply with the Sensex's gain of 6.45%. This stark difference highlights the challenges faced by Remus Pharmaceuticals in the current market environment, where its performance has lagged behind both the sector and the broader market. The absence of any positive factors in the dashboard suggests that there are no current catalysts to support a rebound in the stock's price, further contributing to its downward trend.